The effect of fish-oil supplementation on pregnancy outcomes in mother and infant
- Conditions
- Condition 1: Pregnancy, childbirth and the puerperium. Condition 2: Pregnancy, childbirth and the puerperium. Condition 3: Pregnancy, childbirth and the puerperium. Condition 4: Pregnancy, childbirth and the puerperium. Condition 5: Pregnancy, childbirth and the puerperium. Condition 6: Pregnancy, childbirth and the puerperium. Condition 7: Certain conditions originating in the perinatal period. Condition 8: Certain conditions originating in the perinatal period.Gestational [pregnancy-induced] hypertension with significant proteinuriaDiabetes mellitus in pregnancy, unspecifiedPreterm labour and deliverySingle delivery by caesarean sectionMental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperiumPregnancy-related condition, unspecifiedFetus and newborn affected by maternal nutritional disordersDisorders related to short gestation and low birth weight, not elsewhere classified
- Registration Number
- IRCT2013100914957N1
- Lead Sponsor
- ational Public-Health Management Center (NPMC)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 150
Healthy pregnant women in 16-20 weeks of pregnancy; Aged 18-35 years; 5th pregnancy or less; Singleton pregnancy; No history of infertility and premature birth; Not having history of depression or postpartum depression; Edinburgh depression score less than 23; Absence of known placenta previa or cerclage in this pregnancy; No adverse event occurred 6 months before the study
Exclusion criteria: Smoking or drugs using ;consumption of more than two servings fish per week; Having bleeding disorders or taking anticoagulants; BMI more than 30; participating in another study; Wanting to change living area in the next 6 months; No access to call phone; Being illiterate or unable to answer questions; History of sensitivity to fish oil or other fish products; sensitivity to gelatin; participation in other intervention study; Not willingness to participate; known underlying disease including heart, kidney, stomach, lung, thyroid or autoimmune diseases, diabetes, impaired glucose tolerance in pregnancy, epilepsy, essential hypertension,hyperlipidemia
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postpartum Depression. Timepoint: 6-8 weeks after childbirth. Method of measurement: Edinburgh Depression Scale.;Newborn Weight. Timepoint: Childbirth. Method of measurement: By means of newborns scale into gram.;Infant Neurodevelopment. Timepoint: 4 and 6 month. Method of measurement: ASQ Questionnare.
- Secondary Outcome Measures
Name Time Method